Target intelligence / Profile preview

Chloride transport protein 6 (CLCN6)

Target
CLCN6
Molecular classification
Ion channel, Transporter
01

Overview

Chloride transport protein 6 (CLCN6, ClC-6) is an intracellular, predominantly neuronal, voltage-gated chloride/proton exchanger localized to late endosomes and lysosomes, where it mediates Cl^–/H^+ exchange essential for normal endolysosomal acidification and neuronal function[2][4]. Structurally, it is a dimeric protein with each monomer consisting of an 18-helix transmembrane domain and cytoplasmic cystathionine β-synthase (CBS) domains, and it exhibits complex voltage-dependent gating properties distinct from plasma-membrane CLC channels[2][3]. Loss-of-function or gain-of-function mutations in CLCN6 are established genetic causes of severe early-onset neurodegenerative disease, highlighting its essential role in the nervous system[2][3][4]. There are currently no known drugs that target ClC-6 directly in clinical use.

Other names
ClC-6CLC-6H(+)/Cl(-) exchange transporter 6KIAA0046Chloride channel protein 6Chloride voltage-gated channel 6CONRIBA
02

Mechanism of action

Not established for therapeutic drugs; native action is voltage-gated, pH-sensitive Cl^–/H^+ exchange (antiport) in endosomal compartments[2][4].

03

Biological functions

Endosomal/lysosomal acidificationChloride/proton antiport (Cl^–/H^+ exchange)Regulation of neuron/endosome function
04

Disease associations

Neurodegenerative diseasePotential role in blood pressure regulation
05

Safety considerations

Disease-causing mutations may lead to severe neurodevelopmental and neurodegenerative symptoms, including white matter hypomyelination, muscular hypotonia, global developmental delay, and respiratory dysfunction[2][3].

Beyond the preview

Go deeper on Chloride transport protein 6 (CLCN6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chloride transport protein 6 (CLCN6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call